Chapter 1 T-Cell Immunotherapy Market Overview
1.1 T-Cell Immunotherapy Definition
1.2 Global T-Cell Immunotherapy Market Size Status and Outlook (2017-2031)
1.3 Global T-Cell Immunotherapy Market Size Comparison by Region (2017-2031)
1.4 Global T-Cell Immunotherapy Market Size Comparison by Type (2017-2031)
1.5 Global T-Cell Immunotherapy Market Size Comparison by Application (2017-2031)
1.6 Global T-Cell Immunotherapy Market Size Comparison by Sales Channel (2017-2031)
1.7 T-Cell Immunotherapy Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 T-Cell Immunotherapy Market Segment Analysis by Player
2.1 Global T-Cell Immunotherapy Sales and Market Share by Player (2020-2022)
2.2 Global T-Cell Immunotherapy Revenue and Market Share by Player (2020-2022)
2.3 Global T-Cell Immunotherapy Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 T-Cell Immunotherapy Market Segment Analysis by Type
3.1 Global T-Cell Immunotherapy Market by Type
3.1.1 CAR-T
3.1.2 TCR
3.1.3 TIL
3.2 Global T-Cell Immunotherapy Sales and Market Share by Type (2017-2022)
3.3 Global T-Cell Immunotherapy Revenue and Market Share by Type (2017-2022)
3.4 Global T-Cell Immunotherapy Average Price by Type (2017-2022)
3.5 Leading Players of T-Cell Immunotherapy by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 T-Cell Immunotherapy Market Segment Analysis by Application
4.1 Global T-Cell Immunotherapy Market by Application
4.1.1 Stomach Cancer
4.1.2 Lung Cancer
4.1.3 Colorectal Cancer
4.1.4 Esophagus Cancer
4.1.5 Pancreatic Cancer
4.2 Global T-Cell Immunotherapy Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of T-Cell Immunotherapy by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 T-Cell Immunotherapy Market Segment Analysis by Sales Channel
5.1 Global T-Cell Immunotherapy Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global T-Cell Immunotherapy Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of T-Cell Immunotherapy by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 T-Cell Immunotherapy Market Segment Analysis by Region
6.1 Global T-Cell Immunotherapy Market Size and CAGR by Region (2017-2031)
6.2 Global T-Cell Immunotherapy Sales and Market Share by Region (2017-2022)
6.3 Global T-Cell Immunotherapy Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America T-Cell Immunotherapy Market Share by Type
6.4.3 North America T-Cell Immunotherapy Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe T-Cell Immunotherapy Market Share by Type
6.5.3 Europe T-Cell Immunotherapy Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific T-Cell Immunotherapy Market Share by Type
6.6.3 Asia-Pacific T-Cell Immunotherapy Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America T-Cell Immunotherapy Market Share by Type
6.7.3 South America T-Cell Immunotherapy Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa T-Cell Immunotherapy Market Share by Type
6.8.3 Middle East & Africa T-Cell Immunotherapy Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading T-Cell Immunotherapy Players
7.1 Adaptimmune Therapeutics
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Autolus
7.3 Bluebird Bio
7.4 CARsgen Therapeutics
7.5 Celgene (Juno Therapeutics)
7.6 Cellectis
7.7 Innovative Cellular Therapeutics
7.8 Novartis
7.9 Sinobioway Cell Therapy
7.10 Altor Bioscience Corporation
7.11 Gilead (Kite Pharma)
7.12 Takara Bio
7.13 Unum Therapeutics
7.14 Pfizer
7.15 Aurora BioPharma
7.16 Sorrento Therapeutics
7.17 Mustang Bio
7.18 Collectis
7.19 Allogene Therapeutics
7.20 Celyad
Chapter 8 Upstream and Downstream Analysis of T-Cell Immunotherapy
8.1 Industrial Chain of T-Cell Immunotherapy
8.2 Upstream of T-Cell Immunotherapy
8.3 Downstream of T-Cell Immunotherapy
Chapter 9 Development Trend of T-Cell Immunotherapy (2023-2031)
9.1 Global T-Cell Immunotherapy Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
